item management s discussion and analysis of financial condition and results of operations the following discussion and analysis should be read in conjunction with item selected financial data  risks discussed in other filings made by the company with the securities and exchange commission  and the financial statements and related notes thereto appearing elsewhere in this form k 
when used in the following discussions  the words anticipates  believes  estimates  expects  plans  intends and similar expressions are intended to identify forward looking statements 
such statements are subject to certain risks  uncertainties and contingencies that could cause actual results  performance or achievements to differ materially from those expressed in  or implied by  such statements 
overview from its inception in november through december   the company was in the development stage 
during that period  the company primarily focused on the development of its manufacturing processes in order to transition from laboratory scale to commercial scale production 
as a result  the company developed an operating capacity to produce significant quantities of its nanocrystalline materials for commercial sale 
the company was also engaged in the development of commercial applications and formulations and the recruiting of marketing  technical and administrative personnel 
since january   the company has been engaged in commercial production and sales of its nanocrystalline materials  and the company no longer considers itself in the development stage 
all of the company s revenue since january  has been generated through commercial sources 
from inception through december   the company was primarily capitalized through the private offering of approximately  of equity securities and its initial public offering of  of common stock  each net of issuance costs 
the company has incurred cumulative losses of  from inception through december  results of operations years ended december  and revenue is recorded when the company ships products  when specific milestones are met regarding development arrangements or when the company licenses its technology and transfers proprietary information 
total revenue increased to  in  compared to  in the increase in total revenue between and was primarily attributed to a  increase in product revenue and a  increase in other revenue 
product revenue increased to  in  compared to  in other revenue increased to  in  compared to  in revenue from two major customers constituted approximately of the company s revenue 
in particular  revenue from basf and cik constituted approximately and  respectively  of the company s revenue 
cost of revenue generally includes costs associated with commercial production  customer development arrangements  the transfer of technology  and licensing fees 
cost of revenue increased to  in  compared to  in the increase in cost of revenue was generally attributed to increased product sales  somewhat offset by efficiencies in the manufacture of the company s products and a reduction in the allowance for excess quantities in inventory in as a result of the sale of inventories for which an allowance had previously been provided 
cost of revenue as a percentage of total revenue decreased in  compared to the same period in  due primarily to the increase in total revenue 
research and development expense primarily consists of costs associated with the company s development or acquisition of new product applications and coating formulations and the cost of enhancing the company s manufacturing processes 
research and development expense increased to  in  compared to  in the increase in research and development expense was primarily attributed to additional salaries for newly hired research personnel and increases in internal costs regarding the development of new formulations and product applications 
these increases were partially offset by a reduction in recruiting and relocation expenses in and non recurring payments to a former officer relating to a restructuring in the company expects to further increase its research and development expense in in connection with its plans to continue to enhance and expand its product lines  technologies and manufacturing processes 
selling  general and administrative expense decreased to  in  compared to  in the net decrease was primarily attributed to non recurring restructuring costs  including payments to former officers in  and decreased legal expenses in these decreases were partially offset in by additional rent expense relating to the company s new facility  and increased investor relations and printing costs 
interest income increased to  in  compared to  in this increase was primarily due to an increase in investment yields which was somewhat offset by a reduction in funds available for investment 
there was no income tax expense for the years ended december  and years ended december  and total revenue increased to  in  compared to  in the increase in total revenue between and was primarily attributed to a  increase in other revenue offset by a  reduction in product revenue 
product revenue decreased to  in  compared to  in other revenue increased to  in  compared to  in revenue from three major customers constituted of the company s revenue 
in particular  revenue from cik  a cosmetics customer and a ceramics customer constituted approximately   and  respectively  of the company s revenue 
the company does not currently anticipate future revenue from either the cosmetics customer or the ceramics customer 
cost of revenue decreased to  in  compared to  in the decrease in cost of revenue was generally attributed to cost reduction activities and efficiencies in the manufacture of the company s products  decreased ceramic superplastic forming costs  and a smaller increase in the allowance for excess quantities in inventory in than in cost of revenue as a percentage of total revenue decreased in  compared to the same period in  due primarily to the factors discussed above 
research and development expense decreased to  in  compared to  in the decrease in research and development expense was primarily attributed to the lack of costs relating to arrangements with outside parties to further develop end use products utilizing nanocrystalline materials  versus  of such costs in  offset by increases in salaries  related recruiting and relocation  and payments to a former officer 
selling  general and administrative expense increased to  in  compared to  in the net increase was primarily attributed to costs associated with an organizational restructuring  including recording amounts due to former officers and non cash stock compensation charges relating to the revision of vesting schedules for options previously granted to such officers  associated legal and professional fees  and severance to other employees 
these increases were somewhat offset by an adjustment of estimated amounts related to contingent liabilities  a reduction in recruiting and relocation costs  and a reduction in bad debt expense 
interest income decreased to  in  compared to  in this decrease was primarily due to a reduction in funds available for investment compounded by a reduction in investment yields 
there was no income tax expense in  compared to  in the expense was due to the foreign taxes withheld from license fees received from cik 
the payment of such taxes creates a foreign tax credit which may be available to offset federal income taxes when the company generates taxable income 
liquidity and capital resources the company s cash  cash equivalents and investments amounted to  at december   compared to  at december  the net cash used in the company s operating activities was   and  for the years ended december    and  respectively 
the net cash used in operating activities for the year ended december  was primarily for the further development of product applications  the funding of research and development activities  sales efforts  and the funding of trade receivables  and prepaid expenses  offset by increases in accounts payable and a decrease in the other receivable 
net cash provided by investing activities  which is due to maturities of securities offset somewhat by capital expenditures and purchases of securities  amounted to   and  for the years ended december    and  respectively 
capital expenditures  primarily related to the further expansion of the company s existing manufacturing facilities and the purchase of operating equipment  amounted to   and  for the years ended december    and  respectively 
net cash provided by financing activities  which related to the issuance of shares of common stock pursuant to the exercise of options and warrants  a promissory note  and an insurance finance agreement amounted to  for the year ended december   compared to  for the year ended december   which related to the exercise of options for  shares of common stock  and  for the year ended december  which related to the exercise of options for  shares of common stock 
in  the company borrowed  from basf  as part of a million promissory note  in order to finance the construction of a coating line in its romeoville  illinois facility 
the note bears interest at per annum with the first payment commencing on june  payments are to be made on a per kilogram basis  as invoiced 
any remaining outstanding balance at june  shall become payable on demand at that time 
the company also financed  in insurance premiums 
this agreement bears interest at per annum through september in september  the interest rate will be adjusted to the day libor rate plus 
expected monthly payments will be approximately  through july the company believes that cash on hand  together with the remaining net proceeds from the company s initial public offering of common stock and interest income thereon  will be adequate to fund the company s current operating plans 
the company s actual future capital requirements will depend  however  on many factors  including customer acceptance of the company s current and potential nanocrystalline materials and product applications  continued progress in the company s research and development activities and product testing programs  the magnitude of these activities and programs  and the costs necessary to increase and expand the company s manufacturing capabilities and to market and sell the company s materials and product applications 
depending on future requirements  the company may seek additional funding through public or private financing  collaborative relationships  government contracts or additional licensing agreements 
additional financing may not be available on acceptable terms or at all  and any such additional financing could be dilutive to the company s stockholders 
at december   the company had a net operating loss carryforward of approximately million for income tax purposes 
because the company may have experienced ownership changes within the meaning of the us internal revenue code in connection with its various prior equity offerings  future utilization of this carryforward may be subject to certain limitations as defined by the internal revenue code 
if not utilized  the carryforward expires at various dates between and as a result of the annual limitation and uncertainty as to the amount of future taxable income that will be earned prior to the expiration of the carryforward  the company has concluded that it is likely that some portion of this carryforward will expire before ultimately becoming available to reduce income tax liabilities 
at december   the company also had a foreign tax credit carryforward of  which could be used as an offsetting tax credit to reduce us income taxes 
the foreign tax credit will expire in if not utilized before that date 
item a 
quantitative and qualitative disclosures about market risk the company does not have any material market risk sensitive instruments 

